Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Hepatoblastoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 8Radiotherapy 7Temozolomide 5Carboplatin 5Vincristine 4etoposide phosphate 3Methotrexate 3Etoposide 3Busulfan 3Biopsy 3Thiotepa 2Surveys and Questionnaires 2Melphalan 2Magnetic Resonance Imaging 2Lomustine 2Cisplatin 2Chemotherapy, Adjuvant 2alovudine 1Yoga 1Ursodeoxycholic Acid 1Topotecan 1Stem Cell Transplantation 1Rituximab 1Remote Consultation 1Radiation 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Paclitaxel 1Oxycodone 1Ocoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Central Nervous System Neoplasms × Ursodeoxycholic Acid × Clear all
NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡